Key Companies Compiled in the Global Hearing Aids Market Research Report by Kenneth Research Include Sonava, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD., Audina Hearing Instruments, Inc., and others.
New York, Aug. 10, 2022 (GLOBE NEWSWIRE) -- For the forecast period, 2022-2031, Kenneth Research has released a thorough market study on the “Global Hearing Aids Market” that covers the following elements:
Market growth over the forecast period
Key market players and their detailed profiling
Global Hearing Aids Market Size:
The global hearing aids market is expected to generate almost USD 12 billion in sales by 2031, expanding at a CAGR of ~ 7% over the forecast period. Increased hearing loss instances and higher noise exposure are two factors contributing to the expansion of the market. According to the World Health Organization (WHO), approximately 2.5 billion individuals would have some hearing impairment by 2050 and around 700 million would need hearing remediation. Furthermore, the demand for hearing aids is also being spurred by an elderly population upsurge, besides rise in vascular disorders, and chronic inflammation. For instance, the Population Reference Bureau estimates that during 2020 -2060, geriatric population is predicted to rise by 69 percent in the United States from 56.0 million to 94.7 million. Age is the best predictor of hearing loss among persons between 20 to 69 years age-group with the most hearing loss occurring between 60 to 69 years. In addition to that, the market is also anticipated to expand as a result of technological developments in hearing aids, as well as growing awareness and activities linked to hearing loss and subsequent measures.
Get Sample Copy of This Report @ https://www.kennethresearch.com/sample-request-10070588
Global Hearing Aids Market: Key Takeaways
North America region acquires the highest share of the revenue
Behind the ear sub-segment (BTE) to remain most lucrative
Pediatrics segment to drive the revenue stream
Rising Noise Pollution and Adoption of Hearing Aids to Boost the Market
According to the estimates 12.5 percent of adolescents and children aged (6-19 years old) and 17 percent of adults (20-69 years old) experience irreversible hearing loss as a result of exposure to loud noises. This equates to roughly 5.2 million children and adolescents and 26 million adults. Destruction of inner ear structures or nerve fibers that respond to sound can cause hearing loss. A single exposure to a particularly loud sound or blast can cause hearing loss, as can listening to loud sounds continuously for a lengthy period of time. In total, 736,900 cochlear implants have been inserted in 2019. Approximately, 118,100 adults and 65,000 children had gadgets implanted in the U.S. The global hearing aids market is anticipated to be fueled by excessive noise pollution and expanding hearing aids applications.
Browse to access In-depth research report on Global Hearing Aids Market with detailed charts and figures: https://www.kennethresearch.com/report-details/global-hearing-aids-market/10070588
Global Hearing Aids Market: Regional Overview
The global hearing aids market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa region.
Growing Cases Solidify Substantial Growth Potential in North America
The National Institute of Deafness and other Communication Disorders (NIDCD) estimated in 2021 that 50 percent of Americans who were 75 years and older and 25 percent of Americans who were 65 to 74 suffer from disabling hearing loss, and that is incapacitating. In addition to the geriatric population, hearing loss affects children as well. 1 in 8 Americans (13 % or 30 million) who are 12 years of age or older have hearing loss in both ears. The hearing aids market in North America is driven by rising adoption of hearing aids and the prevalence of hearing loss. The adoption of hearing aids could be advantageous for about 28.8 million American adults.
Growing Geriatric Population to Favor Growth in the Asia Pacific Region
On account of sizable aging population and elevated amounts of noise pollution in developing nations such as China and India, the Asia Pacific region is anticipated to witness the fastest market development during the forecast period. One of the world’s fastest-flourishing aging populations is in China. Owing to the rising average lifespan and dropping fertility rates, 402 million persons, or 28 percent of China’s population is expected to be over 60 by 2040. There were 176 million geriatric people aged 65 and above and 254 million older individuals aged 60 and over in 2019. The rising number of aging people is predicted to increase the demand for hearing aids and propel the growth of the market.
Get a Sample PDF of Global Hearing Aids Market @ https://www.kennethresearch.com/sample-request-10070588
Furthermore, the biggest source of noise pollution in India is automobiles, which account for 65 to 75 percent of all noise in cities during 2020-2022. Whereas in China, noise pollution is a major concern for 30 % of cities. About 75% of cities in China recorded very high noise pollution during the nights in around 310 Chinese cities considered in the survey. Long-term exposure to sounds louder than 60dB can damage hearing and even cause deafness. The high levels of noise pollution raise the demand for hearing aids and boost the hearing aids market in the region.
The study further incorporates Y-O-Y growth, demand & supply and forecasts future opportunities in:
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe)
Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia,) Australia, New Zealand, Rest of Asia Pacific)
Middle East and Africa (Israel, GCC, [ Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East, and Africa)
Global Hearing Aids Market, Segmentation by Product
Completely in the Canal (CIC)
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.kennethresearch.com/sample-request-10070588
The behind the ear (BTE) sub-segment is predicted to account for the lion’s share of the market over the forecast period, owing to economic circumstances and the low cost of BTE gadgets. A BTE device lies behind the ear after hooking over the top. This design is suitable for all ages and any kind of deafness. Global export value for BTE had a noteworthy raise during 2020-2021. In 2020 the export value was USD 3,956,093 thousand which rose to USD 6,045,740 thousand in 2021 with an annual growth value of 34% during 2020-2021. Growth in the trade is predicted to boost the growth of the segment.
Global Hearing Aids Market, Segmentation by Patient Type
The pediatrics segment is anticipated to grow most lucratively backed by genetics, maternal infections during pregnancy, other environmental factors, and postpartum problems. In 2019, it was discovered that nearly, 6,000 American new-borns had permanent hearing loss. Whereas 98% of babies in the U.S. had their ears tested. Additionally, 1.7 out of every 1,000 new-borns who had hearing tests had hearing loss. The rising rate of hearing loss in infants is projected to fuel the growth of the segment. Furthermore, 50%-60% of infants have genetic hearing loss in 2019.
Leading market players in global hearing aids market that are compiled by Kenneth Research include Sonova, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD Audina Hearing Instruments, Inc., and others.
Enquiry before Buying This Report @ https://www.kennethresearch.com/sample-request-10070588
Recent Developments in Global Hearing Aids Market
February 2022: In its popular Virto series of personalized hearing aids which includes the much-awaited Virto P Black, a fully connected in-the-ear (ITE) hearing device, resembling a earbud, Phonak announced the availability of its best-selling Paradise technology in Virto series.
March 2022: In order to enter China’s rapidly expanding hearing aids industry, Demant A/S recently announced the acquisition of 20% of Sheng Wang, a major network of hearing aids clinics in China.
Gaucher Disease Treatment Market Segmentation by Disease Type {Type 1 (Neuropathic Form), Type 2 (Perinatal Lethal Form), and Type 3 (Slow-Neurologic Decay Form)}; by Treatment Type {Enzyme Replacement Therapy (ERT), and Substrate Reduction Therapy (SRT)}; and by Application (Hospitals, Ambulatory Surgical Centers, and Clinical Research Institutes)-Global Demand Analysis & Opportunity Outlook 2031
Breast Cancer Therapy Market Segmentation by Therapy (Hormonal Therapy, Targeted Therapy, Immunotherapy, and Chemotherapy); by Cancer Type [In situ {Ductal Carcinoma In Situ (DCIS)}, and Invasive {Invasive Ductal Carcinoma (IDC), and Invasive Lobular Carcinoma (ILC)}]; and by Route of Administration (Oral, and Injectable)-Global Demand Analysis & Opportunity Outlook 2031
Bone Growth Stimulators Market Segmentation by Product (Device [Implant & External], Bone Morphogenetic Protein [BMP], Platelet-rich Plasma [PRP], and Others); by Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery, and Others); by End-Use (Hospital, Homecare, and Academic & Research Institutes)-Global Demand Analysis and Opportunity Outlook 2022-2030
Hemostasis and Tissue Sealing Agents Market Segmentation by Product Type (Topical Hemostats, Adhesive, and Tissue Sealant); by Material Type (Collagen Based, Gelatin Based, and Others); and by End User (Hospitals, Ambulatory Surgical Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Allergy Diagnostics Market Segmentation by Product & Service (Assay Kits, Instruments, Services, and Consumables); by Tests (In-Vivo Tests and In-Vitro Tests); by Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, and Others); and by End-Users (Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Web: https://www.kennethresearch.com/
New drugs from Eli Lilly and Novo Nordisk have shown striking results in studies. If insurers step up to back them, the drugs—and the stocks—could take off.
UNITY Biotechnology Inc (NASDAQ: UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for diabetic macular edema (DME). DME is a diabetic complication that affects the blood vessels in the back of your eye. At 18 weeks after a single UBX1325 injection, the mean change in BCVA of UBX1325-treated subjects was an increase of 6.1 ETDRS letters, representing an improvement of +5.0 ETDRS letters compared to sham-treated subjects. Related: UNITY Biotech Stock
Vaxxinity missed out on Operation Warp Speed and the first round of COVID-19 vaccines, but CEO Mei Mei Hu is focused on the second generation and ongoing global needs.
Big pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN), decline due to the litigation surrounding the heartburn drug Zantac (ranitidine).
In the recall expansion, “botulism” has been mentioned.
A prostate cancer drug for terminal patients which can put the disease on hold for a year has been given the green light by regulators.
The study, which was recently published in the journal “Scientific Reports,” found that gait patterns among Japanese children aged 6 to 12 vary from those in other developed countries. Age related variations in lower limb movements while walking were studied by scientists from Nagoya University in Japan. For Japanese children in the 11-12 year age group, the number of steps performed each minute was higher than those in the 6-8 year age group.
When it comes to liver health, many people focus on one thing that's known to cause problems: excessive alcohol. But experts say you're probably consuming something else that could be putting this vital organ in distress. Eating too much of this one popular food may cause non-alcoholic fatty liver disease (NAFLD), which can easily lead to serious complications. As NAFLD progresses, it can lead to inflammation and compromised function, which in turn can cause scarring (cirrhosis), swelling, liver
Bristol Myers (BMY) and partner, 2seventy bio, report top-line data from a late-stage study evaluating Abecma for multiple myeloma patients after two or more lines of prior therapy.
Cancer is the second leading cause of death in the United States, after heart disease and while no cancer is 100 percent avoidable, there are ways to help lower your chances. Age and family history are factors you can't change, but Yevgeniy Skaradinskiy, DO, medical oncology/hematology at Staten Island University Hospital tells us, "Certain lifestyle choices increase risks of cancer, consider smoking cessation, weight loss, change of eating habits, choice of food/schedule of eating, and exercise
SouthCoast LGBTQ+ Network plans to hold a virtual symposium with local health care professionals on Aug. 24 to raise awareness about monkeypox.
A few weeks ago, after more than two years of evading COVID-19, I tested positive on a home rapid test.
The U.S. Centers For Disease Control and Prevention has relaxed some guidelines around COVID-19, including the quarantine recommendation for people who have been exposed. Officials say the new guidelines are meant to educate people on how to stay safe without causing much disruption to life, school and work.
Palm Springs resident Kyle Wilkins received a Jynneos vaccine then noticed sores and other typical monkeypox symptoms two days later.
The spittle of a sneezing, sniffling guy somehow went through his mask and landed on my forehead. He had la corona. I didn't.
The FTSE 100 pharmaceutical giant's share price suffered its biggest drop since 1998 on Thursday.
The House moved Friday to pass a sweeping climate and health care bill, delivering a long-awaited legislative win to President Biden’s desk for his signature. The White House is preparing to deploy officials across the country to promote the historic action on climate change and lowering prescription drug costs contained in the bill, pitching it…
Brian Bonds was one of the first reported cases of MPV in Nevada — and hopes speaking out will help reduce its stigma.
Transgender Floridians of all ages will soon no longer be able to use Medicaid to help pay for gender-affirming care under a new state rule, a move that comes as Gov. Ron DeSantis's administration pursues policies increasing restrictions on medical treatments like puberty blockers and hormone therapy. Florida joins at least 10 other states - including Arizona, Missouri and Texas - in barring residents from using Medicaid to pay for several often-prescribed medications and surgeries for those dia
Friends up north and across Tampa Bay snickered when Brian Lafferty revealed where he’d bought a new home. His 30-year-old daughter in Boston called to express concern. Even his ex-wife asked him about it. “Without exception, every person I’ve told I bought a house in The Villages has asked the same thing,” Lafferty said. “‘Isn’t that the STD capital of the United States?’” The Villages, a ...